menu
    • menu

    Company profile for Alterome Therapeutics

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. We are a team with expertise in multiple areas of science and operations, dedicated to co-elevating toward our vision to bring life-changing and life-saving therapies to cancer patients. We believe in our journey, in each other, and in our ability to collaboratively deve...
    Alterome Therapeutics, Inc. is a precision oncology biotech developing alteration-specific therapeutics to address high value and validated oncogenic drivers. We are a team with expertise in multiple areas of science and operations, dedicated to co-elevating toward our vision to bring life-changing and life-saving therapies to cancer patients. We believe in our journey, in each other, and in our ability to collaboratively develop therapies that will help end cancers. Thus, we seek the best people for our company and provide the resources they need to grow, develop, and accomplish our collective goals.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Alterome TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    13520 Evening Creek Drive North, Suite 430, San Diego, CA 92128
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.alterome.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/alterome/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alterome Therapeutics names new CEO and Board of Director
    Alterome Therapeutics names new CEO and Board of Director

    10 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250410628489/en/Alterome-Therapeutics-Announces-New-Chief-Executive-Officer-and-Chair-of-the-Board-of-Directors

    BUSINESSWIRE
    10 Apr 2025
    Share Share
    Alterome Doses First Patient In Ph1 ALTA3263 (Pan-KRAS Inhibitor)
    Alterome Doses First Patient In Ph1 ALTA3263 (Pan-KRAS Inhibitor)

    10 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250310531954/en

    BUSINESSWIRE
    10 Mar 2025
    Share Share
    Alterome Doses 1st Patient in Ph 1 Study for AKT1 Mutant Tumors
    Alterome Doses 1st Patient in Ph 1 Study for AKT1 Mutant Tumors

    30 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241030626999/en

    BUSINESSWIRE
    30 Oct 2024
    Share Share
    Alterome Presents Preclinical Data for ALTA3263 at ENA Symposium
    Alterome Presents Preclinical Data for ALTA3263 at ENA Symposium

    25 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241025855467/en

    BUSINESSWIRE
    25 Oct 2024
    Share Share
    Alterome CEO Eric Murphy Named Top 100 Entrepreneur By Goldman Sachs
    Alterome CEO Eric Murphy Named Top 100 Entrepreneur By Goldman Sachs

    17 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241017654384/en

    BUSINESSWIRE
    17 Oct 2024
    Share Share
    Alterome Presents Pre-Clinical Data Supporting the Development of Lead Program
    Alterome Presents Pre-Clinical Data Supporting the Development of Lead Program

    08 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240408455695/en

    BUSINESSWIRE
    08 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search